Test Price
2,800 AEDโ Home Collection Available
LAMA2 Gene Muscular Dystrophy Type 1A Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The LAMA2 Gene Muscular Dystrophy Type 1A (MDC1A) Genetic Test analyzes the entire coding region of the LAMA2 gene using Next Generation Sequencing (NGS). This test is essential for confirmatory diagnosis, carrier screening, and familial risk assessment of merosin-deficient congenital muscular dystrophy.
Test Methodology Comparison
| Feature | Our Test (LAMA2 NGS) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | Full gene coverage, detects SNVs, indels, CNVs | Limited to targeted exons only |
| Methodology | Next Generation Sequencing (NGS) with bioinformatic analysis | Sanger sequencing |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks (partial analysis) |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics, I emphasize that genetic testing for LAMA2 mutations must be interpreted in the context of full clinical and family history; a negative result does not exclude other congenital muscular dystrophies and a multidisciplinary team is crucial for ongoing management.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403Important Advisory
Clinical caution: Do not discontinue any prescribed medication or therapy without consulting your physician. Genetic test results require careful interpretation alongside clinical findings. Multidisciplinary management is essential for optimal patient outcomes.
Exclusion Criteria & Emergency Red Flags
- Patients with acute respiratory distress or severe cardiac instability should not undergo home phlebotomy; direct hospital admission is advised.
- If the patient experiences sudden worsening muscle weakness, difficulty swallowing, or breathing issues before sample collection, seek emergency medical care immediately.
- Test is not recommended for individuals with known hypersensitivity to latex or phlebotomy-related materials unless appropriate precautions are available.
Patient FAQ & Clinical Guidance
1. What is the LAMA2 NGS test, and how accurate is it for diagnosing congenital muscular dystrophy type 1A?
The LAMA2 NGS test directly sequences the entire LAMA2 gene with over 99% analytical sensitivity and specificity for pathogenic variants causing merosin-deficient congenital muscular dystrophy. Additional clinical correlation and confirmatory testing such as muscle biopsy or immunohistochemistry may be recommended.
2. Can this test be performed on infants, and what are the sample requirements?
Yes, the test is suitable for all ages including neonates; we accept a blood sample (1โ2 mL in EDTA), extracted DNA, or a single drop of blood on an FTA card. No fasting is needed, and we provide pediatric-friendly home collection kits.
3. How long until I receive my results, and will a specialist explain them?
Results are typically available within 3โ4 weeks and include a comprehensive clinical report reviewed by a board-certified clinical geneticist. You will receive a telephonic consultation with our Consultant Medical Genetics to interpret the findings and discuss next steps.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This test adheres to UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and safety protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Laboratory licensed by Dubai Health Authority (DHA Facility License: 1143). ISO 9001:2015 Certified.
Clinical & Logistical Metadata
| Test Name | LAMA2 Gene Muscular Dystrophy Type 1A (MDC1A) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next Generation Sequencing (NGS) with Bioinformatic Analysis |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 93590-0 |
| DHA Facility License & Laboratory Address | DHA Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians